Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • Other • BioTech • Retail (& E-Commerce) • Medical Devices (& Hospital Services) |
Stages | Pre Seed |
Investing | United States • Hong Kong |
Investment Range | $110,000,000 - $110,000,000 |
Orchid Asia Group Management is a private equity and venture capital firm known for their extensive experience in the Asia market. With a focus on the Chinese-speaking world, they specifically target expanding domestic enterprises and entry businesses that demonstrate strong growth potential in the consumer services and products sector, as well as in the outsourced manufacturing and services sector. Their investment strategy encompasses a diverse range of industries including Software, BioTech, Retail & E-Commerce, and Medical Devices & Hospital Services. The firm has positioned itself as a specialist in Pre Seed stage investments, with both a minimum and maximum investment size of $110,000,000 - indicating a highly focused investment approach. Orchid Asia Group manages substantial assets, with funds that are sustained by capital commitments from a robust network of institutional investors, private banks, university endowments, insurance companies, public and private pension funds, and affluent family offices. Since its inception in 1993, Orchid Asia Group Management has developed a strong foundation and has grown to manage assets totaling approximately US$3 billion. They maintain an active presence with offices situated in key Asian cities: Hong Kong, Shanghai, Beijing, and Guangzhou. This geographical spread not only signifies their intrinsic knowledge of local markets but also their dedication to be closely aligned with their portfolio companies and investors.